Skip to Main Content

Paper Details

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).
J Clin Oncol
74
2022
Early Breast Cancer, PATIENTS, Palbociclib, advanced breast cancer, breast cancer, cancer, cyclin-dependent kinase 4 and 6, early breast cancer, hormone receptor, hormone receptor-positive breast cancer, human, human epidermal, human epidermal growth factor receptor 2, palbociclib, patients
Author NameAffiliation
Antonio C WolffJohns Hopkins University
Eric P WinerDana-Farber Cancer Institute
Ingrid A MayerVanderbilt University Medical Center
  • 1 - 3

Datasets

Release 1.2